The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Apr. 11, 2023
Filed:
Mar. 16, 2017
Applicant:
Oxular Limited, Oxford, GB;
Inventors:
Robert Steven Bley, Menlo Park, CA (US);
Stanley R. Conston, San Carlos, CA (US);
Ronald Yamamoto, San Francisco, CA (US);
Assignee:
Oxular Limited, Oxford, GB;
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61F 9/00 (2006.01); A61K 9/16 (2006.01); A61K 31/573 (2006.01); A61K 9/00 (2006.01); A61K 9/50 (2006.01); A61K 9/70 (2006.01); A61K 31/165 (2006.01); A61K 31/192 (2006.01); A61K 31/196 (2006.01); A61K 31/407 (2006.01); A61K 31/436 (2006.01); A61K 35/28 (2015.01); C07K 16/24 (2006.01); C12N 15/113 (2010.01); A61M 5/19 (2006.01); A61M 5/315 (2006.01); A61M 5/32 (2006.01); A61M 5/20 (2006.01);
U.S. Cl.
CPC ...
A61F 9/0017 (2013.01); A61K 9/0024 (2013.01); A61K 9/0048 (2013.01); A61K 9/0051 (2013.01); A61K 9/1635 (2013.01); A61K 9/1641 (2013.01); A61K 9/1647 (2013.01); A61K 9/1652 (2013.01); A61K 9/5015 (2013.01); A61K 9/5026 (2013.01); A61K 9/5031 (2013.01); A61K 9/5036 (2013.01); A61K 9/5042 (2013.01); A61K 9/5052 (2013.01); A61K 9/5057 (2013.01); A61K 9/70 (2013.01); A61K 31/165 (2013.01); A61K 31/192 (2013.01); A61K 31/196 (2013.01); A61K 31/407 (2013.01); A61K 31/436 (2013.01); A61K 31/573 (2013.01); A61K 35/28 (2013.01); A61M 5/19 (2013.01); A61M 5/31596 (2013.01); A61M 5/329 (2013.01); C07K 16/241 (2013.01); C12N 15/113 (2013.01); A61M 2005/2026 (2013.01); C12N 2310/14 (2013.01);
Abstract
The present invention provides a cannulation device for administering an active agent containing composition to the suprachoroidal space or supraciliary space. The invention provides methods of treatment of an ocular disease or condition accordingly. The invention also provides compositions for use in a method of treatment of an ocular disease or condition for delivery into the suprachoroidal space or supraciliary space.